Rhythm Biosciences (FRA:0RY) FCF Margin %: -4,853.85% (As of Dec. 2025)


FRA:0RY Rhythm Biosciences Ltd FRA:0RY
31 GF Score
Price €0.05
! 6 Warning Signs
View Full Analysis

What is Rhythm Biosciences FCF Margin %?

Rhythm Biosciences FRA:0RY +0.93% 31 FCF Margin % is -4,853.85% as of Dec. 2025. GuruFocus rates FRA:0RY with a GF Score™ of 31/100. The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Rhythm Biosciences ranks worse than 98.04% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Rhythm Biosciences's Free Cash Flow for the six months ended in Dec. 2025 was €-1.26 Mil. Rhythm Biosciences's Revenue for the six months ended in Dec. 2025 was €0.03 Mil. Therefore, Rhythm Biosciences's FCF Margin % for the quarter that ended in Dec. 2025 was -4,853.85%.

As of today, Rhythm Biosciences's current FCF Yield % is -19.20%.

The historical rank and industry rank for Rhythm Biosciences's FCF Margin % or its related term are showing as below:

FRA:0RY' s FCF Margin % Range Over the Past 10 Years
Min: -13261.54   Med: -11776   Max: -11776
Current: -13261.54

During the past 8 years, the highest FCF Margin % of Rhythm Biosciences was -11776.00%. The lowest was -13261.54%. And the median was -11776.00%.

FRA:0RY's FCF Margin % is ranked worse than
98.04% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs FRA:0RY: -13261.54

Rhythm Biosciences FCF Margin % Related Terms

Rhythm Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Rhythm Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhythm Biosciences FCF Margin % Chart

Rhythm Biosciences Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -11,871.43

Rhythm Biosciences Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -4,853.85

FRA:0RY vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Rhythm Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhythm Biosciences FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rhythm Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Rhythm Biosciences's FCF Margin % falls into.


FRA:0RY
31GF Score
Rhythm Biosciences Ltd FRA:0RY
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhythm Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Rhythm Biosciences's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-1.662/0.014
=-11,871.43 %

Rhythm Biosciences's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.262/0.026
=-4,853.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -4,853.85% mean?
Rhythm Biosciences (FRA:0RY) has a FCF Margin % of -4,853.85% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Rhythm Biosciences and its competitors. According to the industry distribution chart, Rhythm Biosciences ranks #200 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 98%.
Is Rhythm Biosciences' FCF Margin % too high?
Rhythm Biosciences' current FCF Margin % is -4,853.85%. Based on the distribution chart, Rhythm Biosciences ranks #200 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Rhythm Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Rhythm Biosciences' FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Rhythm Biosciences ranks #200 out of 204 companies for FCF Margin %. This places Rhythm Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Rhythm Biosciences and its competitors. Rhythm Biosciences's current FCF Margin % is -4,853.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhythm Biosciences stock overvalued right now?
Rhythm Biosciences (FRA:0RY) has a current FCF Margin % of -4,853.85%. The current FCF Margin % is -4,853.85%. Rhythm Biosciences' overall GF Score™ is 31/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Rhythm Biosciences (FRA:0RY), the current FCF Margin % is -4,853.85% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rhythm Biosciences Business Description

Other Exchanges RHY:Australia
Address 30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. The product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.
31GF Score

Get the complete analysis for FRA:0RY

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price